Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received an average rating of "Hold" from the thirty-five analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, twenty-one have issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $54.59.

Several analysts have recently commented on TDOC shares. Bank of America raised their target price on shares of Teladoc Health from $36.00 to $42.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 6th. Piper Sandler reduced their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research note on Thursday, July 28th. KeyCorp assumed coverage on shares of Teladoc Health in a report on Thursday, September 15th. They set a "sector weight" rating for the company. StockNews.com upgraded shares of Teladoc Health to a "sell" rating in a report on Tuesday, August 9th. Finally, Stifel Nicolaus lowered their price target on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th.

Insider Buying and Selling

In related news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total transaction of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,318 shares of company stock worth $255,321. Insiders own 1.55% of the company's stock.

Institutional Inflows and Outflows

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $28.00 on Friday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health has a twelve month low of $24.67 and a twelve month high of $156.82. The stock has a 50 day moving average of $32.86 and a two-hundred day moving average of $40.58. The stock has a market cap of $4.51 billion, a P/E ratio of -0.46 and a beta of 0.93.

Teladoc Health (NYSE:TDOC – Get Rating) last issued its quarterly earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.71) by $0.27. The firm had revenue of $592.38 million during the quarter, compared to the consensus estimate of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. On average, research analysts forecast that Teladoc Health will post -1.54 earnings per share for the current year.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

• Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
• Don't Give Up on These Q3 Losers
• The Anatomy of a Great Pension Plan
• 3 Safe Earnings Plays for a Risk-Off Market
• Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
• Small-Cap Catalyst Pharma Is Among Market's Best Price Performers

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.